News

Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL

Ten years on, Lung-MAP success demonstrates potential of public-private partnerships in clinical research

RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer.

Results of large pragmatic trial will help guide treatment of malignant bowel obstruction in patients with advanced cancer

Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 ASCO Annual Meeting plenary session